Tag: bioequivalence
Provider Case Studies: Real-World Experiences with Generic Medications
Providers share real experiences with generic medications, from seamless substitutions in statins to dangerous seizures from antiepileptic switches. Learn what works, what doesn’t, and how to navigate the patchwork of state rules and patient concerns.
read more
Managing Patient Hesitation About Generics: Proven Communication Strategies for Pharmacists
Learn proven communication strategies pharmacists can use to reduce patient hesitation about generic medications. Based on real data from FDA studies, clinical trials, and patient surveys, this guide shows how to build trust, correct myths, and improve adherence.
read more
FDA Safety Standards: How Generic Drugs Meet Brand Name Drug Requirements
FDA ensures generic drugs match brand-name drugs in active ingredients, dosage, and bioequivalence. With strict testing, manufacturing rules, and oversight, generics are safe, effective, and cost-saving alternatives for millions.
read more
Complex Generic Formulations: Why Proving Bioequivalence Is So Hard
Proving bioequivalence for complex generics like inhalers, topical creams, and liposomal injections is far harder than for regular pills. Without reliable tests, unclear regulations, and reverse-engineering hurdles, only 10-15% of these products get approved-despite a $120 billion market gap.
read more
Bioequivalence of Combination Products: Special Testing Challenges Explained
Bioequivalence testing for combination products like FDCs, topical creams, and inhalers is far more complex than for single-drug generics. Learn why these products face higher failure rates, regulatory hurdles, and how new science is helping generic makers bring down costs.
read more